July 2023

PT staff discusses health outcomes involving SABI, reduced vascular function, and OBA.

Experts answer questions to help provide relief for those suffering with postnasal drip.

Product verification allows technicians to practice at the top of their license and frees pharmacists to interact with patients.

Some devices are being sold OTC for individuals without diabetes to track their health.

Pharmacists should provide guidance on issues such as proper drug disposal and potential drug interactions.

Selection of a different candidate to manage a national nuclear pharmacy chain spurs gender-based discrimination lawsuit.

Pharmacists must carefully consider safety concerns and patient privacy.

Legislation would place emphasis back on patient health rather than on cumbersome, time-consuming paperwork.

A company’s choice of color for branding and logo design may impact how consumers feel about the brand and could influence buyer decision-making.

The approval carries the limitation that bexagliflozin may increase the risk of diabetic ketoacidosis in patients with type 1 diabetes.

This months generic product news includes Nitisinone capsules, Prednisolone tablets, Carboprost Tromethamine injections, and Methsuximide capsules.

Inaccurate information, miscommunication during transition points can have dire consequences.

This months OTC products include brain fuel, SPF 50 mineral sunscreen, women's ensemble, and kids SPF 50 gentle lotion sunscreen.

Mounting concerns about availability of cancer drugs raise questions about the current supply

Identification is key: this silent disease can lead to complications.

Chronic or recurring episodes can lead to other complications.

Further research and regulatory changes are needed, but psychedelic medicines may be able to treat or even cure mental illness in the future.

Without intervention, this may be the tipping point that causes mass closures of pharmacies.